Lataa...
Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches
Acute myeloid leukemia (AML) is a heterogenous and complex disease characterized by rapid cellular proliferation, an aggressive clinical course, and generally high mortality. While progress has been made in the understanding of the genetic and molecular biology of the disease, the standard of care f...
Tallennettuna:
| Julkaisussa: | Ther Adv Hematol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6624910/ https://ncbi.nlm.nih.gov/pubmed/31321011 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620719860645 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|